for either the test or reference product? [Outliers]

posted by mittyri – Russia, 2019-02-05 16:58 (1508 d 05:28 ago) – Posting: # 19871
Views: 6,278

Hi Helmut,

maybe I'm only one who is confused with that statement, but:
3. The subject in question should be identified as an outlier for all parameters, for either the test or reference product, upon which the bioequivalence decision is to be based.

Either? Sorry for my poor grammar knowledge but 'either' is a kind of choice, right? So does it mean we need to find out the outliers using the datasets splitted by formulation, not for the ratio T/R? :confused:

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
22,550 posts in 4,724 threads, 1,606 registered users;
15 visitors (0 registered, 15 guests [including 9 identified bots]).
Forum time: 22:27 CET (Europe/Vienna)

That which is static and repetitive is boring.
That which is dynamic and random is confusing.
In between lies art.    John Locke

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5